|
|
| (89 intermediate revisions by 5 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
| {{SI}} | | {{Pleomorphic adenoma}} |
| {{CMG}} {{AE}} {{MV}}
| | '''For patient information, click [[Pleomorphic adenoma (patient information)|here]]''' |
|
| |
| {{SK}} Pleomorphic adenoma of the salivary glands; BMT; Benign mixed tumors of the salivary gland
| |
|
| |
| ==Overview==
| |
|
| |
|
| '''Pleomorphic adenoma''' (also known as "Benign mixed tumor of the salivary gland") is a benign neoplastic tumor of the [[salivary gland]]s. Pleomorphic adenoma is the most common type of salivary gland tumor and the most common tumor of the [[parotid gland]].<ref name="radiographics">Ewa J. Bialek, Wieslaw Jakubowski, Piotr Zajkowski, Kazimierz T. Szopinski, and Antoni Osmolski. [http://radiographics.rsnajnls.org/cgi/content/abstract/26/3/745 US of the Major Salivary Glands: Anatomy and Spatial Relationships, Pathologic Conditions, and Pitfalls.] RadioGraphics 2006 26: 745-763. </ref>
| | {{CMG}}; {{AE}} {{M.N}} |
|
| |
|
| ==Historical Perspective==
| | {{SK}} |
|
| |
|
| *Pleomorphic adenoma was first discovered by Beahrs in in 1957.
| | ==[[Pleomorphic adenoma overview|Overview]]== |
|
| |
|
|
| | ==[[Pleomorphic adenoma historical perspective|Historical Perspective]]== |
| ==Classification== | |
| *Pleomorphic adenoma may be classified according to [classification method] into [number] subtypes/groups:
| |
| :*[group1]
| |
| :*[group2]
| |
| :*[group3]
| |
| *Other variants of pleomorphic adenoma include [disease subtype 1], [disease subtype 2], and [disease subtype 3].
| |
|
| |
| ==Pathophysiology==
| |
| *The pathogenesis of pleomorphic adenoma is characterized by [feature1], [feature2], and [feature3].
| |
| *The [gene name] gene/Mutation in [gene name] has been associated with the development of pleomorphic adenoma, involving the [molecular pathway] pathway.
| |
| *On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of pleomorphic adenoma.
| |
| *On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of pleomorphic adenoma.
| |
|
| |
| ==Causes==
| |
| *Common causes of pleomorphic adenoma, include:
| |
|
| |
|
|
| | ==[[Pleomorphic adenoma classification|Classification]]== |
| ==Differentiating Pleomorphic Adenoma from Other Diseases== | |
| *Pleomorphic adenoma must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
| |
| :*[Differential dx1]
| |
| :*[Differential dx2]
| |
| :*[Differential dx3]
| |
|
| |
| ==Epidemiology and Demographics==
| |
| * The prevalence of pleomorphic adenoma is approximately [number or range] per 100,000 individuals worldwide.
| |
| * In [year], the incidence of pleomorphic adenoma was estimated to be [number or range] cases per 100,000 individuals in [location].
| |
|
| |
| ===Age===
| |
|
| |
|
|
| | ==[[Pleomorphic adenoma pathophysiology|Pathophysiology]]== |
| *Pleomorphic adenoma is more commonly observed among patients aged [age range] years old.
| |
| *Pleomorphic adenoma is more commonly observed among [elderly patients/young patients/children].
| |
|
| |
| ===Gender===
| |
| *Pleomorphic adenoma affects men and women equally.
| |
|
| |
| *[Gender 1] are more commonly affected with pleomorphic adenoma than [gender 2].
| |
| * The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.
| |
|
| |
| ===Race===
| |
| *There is no racial predilection for pleomorphic adenoma.
| |
|
| |
| ==Risk Factors==
| |
| *Common risk factors in the development of pleomorphic adenoma, include:
| |
|
| |
| == Natural History, Complications and Prognosis==
| |
|
| |
|
| *The majority of patients with pleomorphic adenoma remain asymptomatic for [duration/years].
| | ==[[Pleomorphic adenoma causes|Causes]]== |
| *Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
| |
| *If left untreated, the majority of patients with pleomorphic adenoma may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
| |
| *Common complications of pleomorphic adenoma include [complication 1], [complication 2], and [complication 3].
| |
| *Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with pleomorphic adenoma is approximately [#%].
| |
|
| |
| == Diagnosis ==
| |
| ===Diagnostic Criteria===
| |
| *The diagnosis of pleomorphic adenoma is made when at least [number] of the following [number] diagnostic criteria are met:
| |
| :*[criterion 1]
| |
| :*[criterion 2]
| |
| :*[criterion 3]
| |
| :*[criterion 4]
| |
|
| |
| === Symptoms ===
| |
| *Pleomorphic adenoma is usually asymptomatic.
| |
| *Symptoms of pleomorphic adenoma may include the following:
| |
| :*[symptom 1]
| |
| :*[symptom 2]
| |
| :*[symptom 3]
| |
| :*[symptom 4]
| |
| :*[symptom 5]
| |
| :*[symptom 6]
| |
|
| |
| === Physical Examination ===
| |
| *Patients with pleomorphic adenoma usually appear [general appearance].
| |
| *Physical examination may be remarkable for:
| |
| :*[finding 1]
| |
| :*[finding 2]
| |
| :*[finding 3]
| |
| :*[finding 4]
| |
|
| |
|
|
| | ==[[Pleomorphic adenoma differential diagnosis|Differentiating Pleomorphic Adenoma from other Diseases]]== |
| === Laboratory Findings === | |
| *There are no specific laboratory findings associated with pleomorphic adenoma.
| |
|
| |
|
|
| | ==[[Pleomorphic adenoma epidemiology and demographics|Epidemiology and Demographics]]== |
| ===Imaging Findings=== | |
| *MRI is the imaging modality of choice for pleomorphic adenoma.
| |
| *On CT, characteristic findings of pleomorphic adenoma, include:
| |
| :*Smooth, and well-marginated tumors
| |
| :*The attenuation values of the mass are usually homogeneous and higher than that of the surrounding gland
| |
| :*Tumor enhancement is variable and can result in a missed diagnosis if delayed images are not acquired
| |
| :*Pleomorphic adenomas are poorly enhancing in the early phase of contrast enhancement, though the amount of enhancement increases over time).
| |
|
| |
|
| *On MRI, characteristic findings of pleomorphic adenoma, include:
| | ==[[Xyz risk factors|Risk Factors]]== |
| :*Pleomorphic adenomas are usually well-circumscribed
| |
| :*Homogeneous masses with low intensity on T1-weighted images and high intensity on T2-weighted images.
| |
| :*They commonly have a rim of decreased signal intensity on T2-weighted images.
| |
| :*After gadolinium enhancement, the tumors are homogeneously enhancing unless they are large.
| |
| ====Gallery====
| |
|
| |
|
| <gallery perRow="3">
| | ==[[Pleomorphic adenoma screening|Screening]]== |
| Image:Pleomorphic adenoma MRI 101.jpg|MRI: A right parotid pleomorphic adenoma [http://www.radswiki.net Images courtesy of RadsWiki]
| |
| Image:Pleomorphic adenoma MRI 102.jpg|MRI: A right parotid pleomorphic adenoma [http://www.radswiki.net Images courtesy of RadsWiki]
| |
| Image:Pleomorphic adenoma MRI 103.jpg|MRI: A right parotid pleomorphic adenoma [http://www.radswiki.net Images courtesy of RadsWiki]
| |
| Image:Pleomorphic adenoma MRI 104.jpg|MRI: A right parotid pleomorphic adenoma [http://www.radswiki.net Images courtesy of RadsWiki]
| |
| Image:Pleomorphic adenoma MRI 105.jpg|MRI: A right parotid pleomorphic adenoma [http://www.radswiki.net Images courtesy of RadsWiki]
| |
| Image:Pleomorphic adenoma PET 106.jpg|PET: A right parotid pleomorphic adenoma [http://www.radswiki.net Images courtesy of RadsWiki]
| |
| </gallery>
| |
|
| |
|
| === Other Diagnostic Studies === | | ==[[Pleomorphic adenoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]== |
| *Pleomorphic adenoma may also be diagnosed using [[fine needle aspiration]] (FNA) and core needle biopsy.
| |
| *Findings on [[fine needle aspiration]] (FNA) and core needle biopsy, include:
| |
| :*
| |
| :*
| |
| :*
| |
|
| |
| == Treatment ==
| |
| === Medical Therapy ===
| |
| *There is no treatment for pleomorphic adenoma; the mainstay of therapy is surgery.
| |
| *In some cases, patients with pleomorphic adenoma can receive medications to stimulate saliva production, such as:
| |
| :*Pilocarpine
| |
| :*Cevimeline
| |
|
| |
|
| === Surgery === | | ==Diagnosis== |
| *Surgery is the mainstay of therapy for pleomorphic adenoma.
| | [[Pleomorphic adenoma diagnostic study of choice|Diagnostic study of choice]] | [[Pleomorphic adenoma history and symptoms|History and Symptoms]] | [[Pleomorphic adenoma physical examination|Physical Examination]] | [[Pleomorphic adenoma laboratory findings|Laboratory Findings]] | [[Pleomorphic adenoma electrocardiogram|Electrocardiogram]] | [[Pleomorphic adenoma x ray|X-Ray Findings]] | [[Pleomorphic adenoma echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Pleomorphic adenoma CT scan|CT-Scan Findings]] | [[Pleomorphic adenoma MRI|MRI Findings]] | [[Pleomorphic adenoma other imaging findings|Other Imaging Findings]] | [[Pleomorphic adenoma other diagnostic studies|Other Diagnostic Studies]] |
| *Surgical excision in conjunction with pre-surgical biopsy is the most common approach to the treatment of pleomorphic adenoma.
| |
|
| |
|
| === Prevention === | | ==Treatment== |
| *There are no primary preventive measures available for pleomorphic adenoma.
| | [[Pleomorphic adenoma medical therapy|Medical Therapy]] | [[Pleomorphic adenoma surgery|Surgery]] | [[Pleomorphic adenoma primary prevention|Primary Prevention]] | [[Pleomorphic adenoma secondary prevention|Secondary Prevention]] | [[Pleomorphic adenoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Pleomorphic adenoma future or investigational therapies|Future or Investigational Therapies]] |
| *Once diagnosed and successfully treated, patients with pleomorphic adenoma are followed-up every 6 or 12 months.
| |
| *Follow-up testing includes [test 1], [test 2], and [test 3].
| |
|
| |
|
| | | ==Case Studies== |
| ==References== | | [[Pleomorphic adenoma case study one|Case #1]] |
| {{Reflist|2}}
| |
|
| |
| [[Category:Disease]] | |
| [[Category:Oral pathology]]
| |
| [[Category:Oncology]]
| |